Latanoprost Sandoz (Latanoprost)

Latanoprost is a prostaglandin F‑type receptor agonist. By binding to these receptors in the eye’s ciliary muscle, it increases uveoscleral outflow of aqueous humor, which reduces intraocular pressure and helps manage glaucoma and ocular hypertension.

The prescribed dose of Latanoprost Sandoz is determined by the treating ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact regimen should follow the prescriber’s instructions.

Safety of Latanoprost in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the prescribing clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intraocular pressure reduction. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often have a more favorable dosing schedule and comparable efficacy, though individual response may vary.

Latanoprost Sandoz should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light and moisture, and avoid freezing the solution.

Latanoprost is administered as a single drop into the conjunctival sac of the affected eye(s) once daily, preferably in the evening. Patients should avoid touching the tip of the bottle to the eye or any other surface to maintain sterility.

Serious risks include ocular inflammation such as uveitis or iritis, corneal edema, and severe allergic reactions that may cause eyelid swelling or rash. Any sudden vision changes or persistent eye pain should prompt immediate medical evaluation.

Latanoprost should not be used by patients with known hypersensitivity to prostaglandin analogs or any component of the formulation. It is also contraindicated in individuals with active ocular infections or severe ocular inflammation until these conditions are resolved.